Sector portfolio · Growth fund

NH

Novo Holdings A/S's Biotech portfolio

Novo Holdings A/S has backed 21 Biotech startups in rounds we track, $1.8B between them, shown by the stage each has reached. The best-funded is Symphogen.

21startups backed
4stages
$1.8Braised between them
Series Abiggest stage

Novo Holdings A/S's profile

Segment by segment

Series A

6 startups · $556M raised

  1. Disc MedicineDisc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.United States$275M
  2. MTMirum TherapeuticsUnited States$120M
  3. Hillstar BioHillstar Bio is a Boston-based biotechnology company founded in 2023, specializing in precision immunology.United States$67M
  4. DTDelenex TherapeuticsDelenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.Switzerland$41M
  5. Coave TherapeuticsHorama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.France$33M
  6. Outpost MedicineOutpost Medicine is a biopharmaceutical companyUnited Kingdom$20M

Series C and later

6 startups · $712M raised

  1. Procept BioRoboticsPROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology.United States$210M
  2. GlycomineGlycomine is an early-stage biotech working on replacement therapies for rare diseases.United States$160M
  3. STSynosia TherapeuticsSynosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.Switzerland$92M
  4. CellBiosciencesProteinSimple develops and commercializes proprietary systems and consumables for protein analyzis.United States$85M
  5. AnaptysBioAnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing United States$85M
  6. RRgenixUnited States$81M

Series B

6 startups · $365M raised

  1. Tarsa TherapeuticsTarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.United States$121M
  2. Lux BiosciencesLux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases.United States$90M
  3. ATAristea TherapeuticsAristea Therapeutics is a developer of novel therapies created for autoimmune diseases.United States$78M
  4. AlloCureAlloCure is a clinical-stage biotechnology company based in Burlington, Massachusetts, specializing in cell therapies for kidney dUnited States$47M
  5. NTNora TherapeuticsNora develops therapeutics to address unmet clinical needs in reproductive medicine.United States$21M
  6. KTKarus TherapeuticsKarus Therapeutics is a pharmaceutical research company that develops drugs to treat cancer and heart diseases.United Kingdom$7.6M

Stage not reported

3 startups · $184M raised

  1. SI-BONESI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.United States$102M
  2. MediQuest TherapeuticsMediQuest Therapeutics is a pharmaceutical company providing topical solutions for inflammatory and infectious diseases.United States$44M
  3. PPPanacos PharmaceuticalsPanacos Pharmaceuticals a drug company focused on HIV and other major human viral diseases.United States$38M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Novo Holdings A/S as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Novo Holdings A/S?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.